Article
Minimal sequence requirements for synthetic peptides derived from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) to enhance HIV-1 binding to cells and infection.
Virology - 1 Feb 1995
Zanotto C, Calderazzo F, Dettin M, Di Bello C, Autiero M, Guardiola J, Chieco-Bianchi L, De Rossi A
Abstract excerpt
We previously demonstrated that a 23-mer peptide (DB3) derived from the V3 loop of the surface glycoprotein of HIV-1 MN strain was able to bind to soluble CD4 and enhance HIV-1 infection. The mechanism and structural features required for these biological activities were studied by using shortened DB3 derivatives and DB3 analogs carrying single amino acid substitutions. We found that peptides in which the...
Topics
- Amino Acid Sequence
- Antigens, CD
- Binding Sites
- CD4 Antigens
- Cell Line
- Dose-Response Relationship, Drug
- Enzyme-Linked Immunosorbent Assay
- Flow Cytometry
- Genetic Variation
- HIV Core Protein p24
